KPIs & Operating Metrics(New)
Cash Flow Statement
Growth Metrics

Bausch Health Companies (BHC) Cost of Revenue (2016 - 2026)

Bausch Health Companies' Cost of Revenue history spans 18 years, with the latest figure at $47.0 million for Q1 2026.

  • On a quarterly basis, Cost of Revenue fell 53.92% to $47.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $554.0 million, a 69.94% increase, with the full-year FY2024 number at $449.0 million, up 475.64% from a year prior.
  • Cost of Revenue hit $47.0 million in Q1 2026 for Bausch Health Companies, up from -$4.0 million in the prior quarter.
  • Over the last five years, Cost of Revenue for BHC hit a ceiling of $612.0 million in Q3 2023 and a floor of -$1.7 billion in Q4 2022.
  • Historically, Cost of Revenue has averaged $104.7 million across 5 years, with a median of $102.0 million in 2025.
  • Biggest five-year swings in Cost of Revenue: plummeted 9372.22% in 2022 and later surged 350.44% in 2025.
  • Tracing BHC's Cost of Revenue over 5 years: stood at -$1.7 billion in 2022, then surged by 102.88% to $48.0 million in 2023, then surged by 131.25% to $111.0 million in 2024, then tumbled by 103.6% to -$4.0 million in 2025, then soared by 1275.0% to $47.0 million in 2026.
  • Business Quant data shows Cost of Revenue for BHC at $47.0 million in Q1 2026, -$4.0 million in Q4 2025, and $509.0 million in Q3 2025.